Dominik Dytfeld
- Hematology top 1%
- Multiple Myeloma Research and Treatments 54
- Oncology top 5%
- Peptidase Inhibition and Analysis 12
- CAR-T cell therapy research 10
- Cancer Treatment and Pharmacology 10
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 19
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 12
-
- Lymphoma Diagnosis and Treatment 8
-
- Advanced Proteomics Techniques and Applications 6
- Co-authors
- Andrzej JakubowiakPaul G. RichardsonKenshi SuzukiPhilippe MoreauXavier LeleuMarc S. RaabJesús F. San MiguelNaoki Takezako
- Cited by
- HematologyOncologyMolecular Biology
- Partner nations
- PolandUnited StatesFrance
In The Last Decade
Dominik Dytfeld
62 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Hematology 1.0k
- Oncology 652
- Molecular Biology 920
- Genetics 113
- Cancer Research 76
Countries citing papers authored by Dominik Dytfeld
This map shows the geographic impact of Dominik Dytfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Dytfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Dytfeld more than expected).
Fields of papers citing papers by Dominik Dytfeld
This network shows the impact of papers produced by Dominik Dytfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Dytfeld. The network helps show where Dominik Dytfeld may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dominik Dytfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 26 | |
| 12 | 2017 | 102 | |
| 13 | 2017 | 2 | |
| 14 | 2015 | 40 | |
| 15 | 2014 | 8 | |
| 16 | 2013 | 12 | |
| 17 | 2013 | 4 | |
| 18 | 2012 | 311 | |
| 19 | 2011 | 11 | |
| 20 | Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia. | 2008 | 20 |
About Dominik Dytfeld
Dominik Dytfeld is a scholar working on Hematology, Oncology and Genetics, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (54 papers), Protein Degradation and Inhibitors (19 papers), Chronic Lymphocytic Leukemia Research (12 papers), Peptidase Inhibition and Analysis (12 papers), CAR-T cell therapy research (10 papers), Cancer Treatment and Pharmacology (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Advanced Proteomics Techniques and Applications (6 papers). The work is most often cited by research in Hematology (1.0k citations), Oncology (652 citations) and Molecular Biology (920 citations). Dominik Dytfeld has collaborated with scholars based in Poland, United States and France. Frequent co-authors include Andrzej Jakubowiak, Paul G. Richardson, Kenshi Suzuki, Philippe Moreau, Xavier Leleu, Marc S. Raab, Jesús F. San Miguel, Naoki Takezako, Mihaela Popa McKiver and Meletios Α. Dimopoulos. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, Oncotarget and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.